Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/ajphs/public_html/sites/all/modules/biblio/includes/biblio_theme.inc).

Pharmaceutical Co-crystals: A Review

Asian Journal of Pharmaceutical and Health Sciences,2019,9,3,2115-2118.
Published:February 2020
Type:Review Article
Authors:
Author(s) affiliations:

G. Madhavi, M.V.P.L.Bhavya, T.Lalitha, G. Jyothika, V.V.Bhavana, M.Hema Rani, M.Bhagya Lakshmi, K. Padmalatha

Vijaya Institute of Pharmaceutical Sciences for Women, Enikepadu, Vijayawada-521108, Andhra Pradesh, INDIA.

Abstract:

Co-crystal formation is one of the methods to improve the physico-chemical properties of the active pharmaceutical ingredient. Co-crystallization with pharmaceutically acceptable compounds do not affect the pharmacological activity of the API but can improve physical properties such as solubility, dissolution rate, moisture stability and compaction behavior. Co-crystals are most dynamically developing group of multicomponent solid pharmaceutical substances. Co-crystals can be divided into co-crystal anhydrates, co-crystal hydrates (solvates), co-crystals of salts (unsolvated, unhydrated, solvated or hydrated). Techniques for preparation of co-crystals are solvent evaporation, anti-solvent method, hot melt extrusion and solvent free grinding. Co-crystals are characterized by hot stage microscopy, differential scanning calorimetry, X-ray diffraction, IR and Raman spectroscopy.

Techniques used for preparation of co-crystals